|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/122 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| A61K 31/351 | (2006.01) | ||
| A61K 31/122 | (2013.01) | ||
| A61K 31/4748 | (2006.01) | ||
| A61K 31/522 | (2013.01) | ||
| A61K 31/522 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 39/39558 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 31/4748 | (2013.01) | ||
| A61K 31/351 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3355875 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16782161.0 |
| Date of filing the European patent application | 2016-09-30 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/054731 |
| Date | 2016-09-30 |
| (87) | Number | WO 2017/059224 |
| Date | 2017-04-06 |
| (30) | Number | Date | Country code |
| 201562236064 P | 2015-10-01 | US | |
| 201562269007 P | 2015-12-17 | US |
| (72) |
VENKATARAMAN, Sriram , US
TUMAS, Daniel , US
TANAKA, Kohei , JP
YASUHIRO, Tomoko , JP
YOSHIZAWA, Toshio , JP
|
| (73) |
Gilead Sciences, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
ONO Pharmaceutical Co., Ltd. , 1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, JP |
| (54) | COMBINATION OF A BTK INHIBITOR AND A CHECKPOINT INHIBITOR FOR TREATING CANCERS |
| COMBINATION OF A BTK INHIBITOR AND A CHECKPOINT INHIBITOR FOR TREATING CANCERS |